Cash & equivalents decreased 74.5%
Cash & equivalents changed -74.5% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -74.5% from the comparable as-filed period.
Inventory changed -34.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -105.9% from the comparable as-filed period.
Operating income changed -93.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating margin changed -859 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed -24.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed +22.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross margin changed +210 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross profit changed -19.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -0.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.